RDMD Secures $14M in Financing to Expand Platform for Sanfilippo, Other Rare Disorders
Healthcare technology company RDMD has raised $14 million to further expand its platform seeking to accelerate research and treatment development for rare diseases, including Sanfilippo syndrome. The Series A financing was led by Spark Capital, with participation from Lux Capital, Village Global,…